To assess the role of lysozyme in pulmonary host defense in vivo, transgeni
c mice expressing rat lysozyme cDNA in distal respiratory epithelial cells
were generated. Two transgenic mouse lines were established in which the le
vel of lysozyme protein in bronchoalveolar (BAL) lavage fluid was increased
2- or 4-fold relative to that in WT mice, Lung structure and cellular comp
osition of BAL were not altered by the expression of lysozyme, Lysozyme act
ivity in BAI, was significantly increased (6,6- and 17-fold) in 5-wk-old an
imals from each transgenic line. To determine whether killing of bacteria w
as enhanced by expression of rat lysozyme, 5-wk-old transgenic mice and WT
littermates were infected with 10(6) CFU of group B streptococci or 10(7) C
FU of a mucoid strain of Pseudomonas aeruginosa by intratracheal injection,
Killing of group B streptococci was significantly enhanced (2- and 3-fold)
in the mouse transgenic lines at 6 h postinfection and was accompanied by
a decrease In systemic dissemination of pathogen, Killing of Pseudomonas ae
ruginosa was also enhanced in the transgenic lines (5- and 30-fold). Twenty
-four hours after administration of Pseudomonas aeruginosa, all transgenic
mice survived, whereas 20% of the WT mice died, Increased production of lgs
ozyme in respiratory epithelial cells of transgenic mice enhanced bacterial
killing in the lung in vivo, and was associated with decreased systemic di
ssemination of pathogen and increased survival following infection.